Bone Metastasis and Osteoporosis

• DENOSUMAB - Amgen's Forthcoming Drug, An Inhibitor of Bone Resorption (September 2008)

• Skeletal Scintigraphy With 18F Sodium Fluoride Positron Emission Tomography (18F-fluoride PET) Offers Greater Overall Accuracy Than 99mTechnetium-MDP for Prostate Cancer Patients (May 2008)

• "Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients with High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies" (JCO August 1, 2007) (January 2008)

• Osteonecrosis of the Jaw, Androgen Deprivation, and Bisphosphonates (May 2007)

• Zometa: Once Yearly Dosage Found Effective In Combating Osteoporosis In Men On ADT Without Bone Metastases (November 2006)

• Modified PSA Guidelines For Bone Scanning (October 2006)

• Painful Bone Metastases: RTOG Trial 9701 Finds Response Rate From 8Gy Single Fraction Radiotherapy As Effective As A Longer Course (July 2005)

• The Utility of Bone Scans in Recurrent Prostate Cancer (June 2005)

• Bone Metastases In Prostate Cancer And Therapy With Zometa. (February 2005)

• The use of “Zometa” and “Pamidronate” in prevention of osteoporosis and in retarding the progression of metastases in bone. (November 2002)

« Back to topic index